1CP
BSX icon

1015 Capital Partners’s Boston Scientific BSX Stock Holding History

1015 Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.8K Sell
1,402
-220
-14% -$11.9K 0.05% 139
2026
Q1 		$102K Sell
1,622
-210
-11% -$16.8K 0.1% 120
2025
Q4 		$175K Buy
+1,832
New +$180K 0.17% 92

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

1015 Capital Partners's BSX Position: Q2 2026 in Review

1015 Capital Partners reduced its Boston Scientific (BSX) stake by 14% in Q2 2026, selling an estimated $11.9K and leaving 1,402 shares worth $59.8K. The position accounts for 0.05% of the portfolio, ranked #139.

1015 Capital Partners first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $175K in Q4 2025. 1,464 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • 1015 Capital Partners held 1,402 shares of Boston Scientific worth $59.8K as of Q2 2026.
  • 1015 Capital Partners sold 220 Boston Scientific shares in Q2 2026, an estimated $11.9K.
  • Boston Scientific made up 0.05% of 1015 Capital Partners's portfolio in Q2 2026, its #139 holding.
  • 1015 Capital Partners first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • 1015 Capital Partners's Boston Scientific position peaked at $175K in Q4 2025.
  • 1,464 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on 1015 Capital Partners's 13F filing for Q2 2026, filed 21 Jul 2026.